Vaxart Inc reports results for the quarter ended in December - Earnings Summary

Vaxart

15/03/2023 21:02

* Vaxart Inc  VXRT.OQ  reported a quarterly adjusted loss
of 18
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 23 cents per share.
    * Revenue fell 70.3% to $22.00 thousand from a year ago;
analysts
expected $675.00 thousand. 
    * Vaxart Inc's reported EPS for the quarter was a loss of 18
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vaxart Inc shares had fallen by 17.8% this quarter.
    * The company reported a quarterly loss of $23.92 million.
    * Wall Street's median 12-month price target for Vaxart Inc
is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 15 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.23          -0.18          Beat
 Sep. 30 2022      -0.24          -0.23          Beat
 Jun. 30 2022      -0.21          -0.23          Missed
 Mar. 31 2022      -0.16          -0.20          Missed